Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hong Kong and Australia Biotech Groups Boost Cooperation

This article was originally published in PharmAsia News

Executive Summary

The two groups hope member companies will benefit from Australia's expertise and Hong Kong's start-up scene.

You may also be interested in...

Lack Of Funding and Political Will Hinders Hong Kong’s Untapped Drug Discovery Research – ChinaBio Investor Forum

HONG KONG - Generally overshadowed by Singapore or Taiwan as a pharmaceutical and biotech center in Southeast Asia, Hong Kong has deep reserves of untapped knowledge and intellectual property

China’s Simcere Receives Buyout Offer From Its Chairman, But Could Delisting Be A Negative Overseas?

Simcere would join Chinese firms 3SBio and ShangPharma in pulling out of the U.S. stock market.

China’s New Good Supply Practices Regs Require Electronic Barcodes; Raise Bar To Entry

The Ministry of Health’s GSP regulation tries to plug a hole in supply chain security through tighter IT controls, such as requiring electronic barcodes.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts